ARTICLE | Company News
Evolva Holding infectious news
September 30, 2013 7:00 AM UTC
Evolva said the U.S. Defense Threat Reduction Agency selected the biotech to enter into contract negotiations for potential preclinical funding of up to $14.7 million to develop GC-072. Evolva said th...